30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

ELI LILLY & Co

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
1.5
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
ELI LILLY & Co's trades of Sigilon Therapeutics, Inc.'s stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-08-14 2023-08-11 B Purchase
88,597 +49.2%
293.20
US$3,904,546
88,597 +49.2% 293.20 US$3,904,546
2020-12-10 2020-12-08 B Purchase
34,828 +27.7%
150.21
US$836,688
34,828 +27.7% 150.21 US$836,688
2019-02-04 2019-01-31 S Sale
32,329 -28.4%
129.43
US$2,924,768
32,329 -28.4% 129.43 US$2,924,768